Marc Rubin Insider Trading $TTNP TITAN PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marc Rubin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marc Rubin. Marc Rubin is Director in MEDAREX INC ($MEDX) and Executive Chairman in TITAN PHARMACEUTICALS INC ($TTNP) and Director in CURIS INC ($CRIS) and Director in GALECTIN THERAPEUTICS INC ($GALT).
Marc Rubin in TITAN PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Rubin: Executive Chairman
Holdings: 556,317 shares
Current Value: $2,197,452
Latest Transaction: Feb 11 2021
$TTNP Market Capitalization: $81.61M
$TTNP Previous Close: $3.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Marc Rubin in TITAN PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRIS, GALT, MEDX, TTNP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 4.02 | 150,000 | 603,000 | 150,000 | |
| Apr 03 2019 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
| Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.25 | 400,000 | 100,000 | 400,000 | |
| Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.25 | 400,000 | 100,000 | 556,317 | 156.3 K to 556.3 K (+255.89 %) |
| Mar 09 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.97 | 170,000 | 164,900 | 170,000 | |
| Feb 14 2017 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 3.90 | 70,000 | 273,000 | 70,000 | |
| Feb 02 2016 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 5.10 | 79,100 | 403,410 | 79,100 | |
| Jan 11 2016 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 3.25 | 5,000 | 16,250 | 156,317 | 151.3 K to 156.3 K (+3.30 %) |
| Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 5.10 | 170,000 | 867,000 | 170,000 | |
| Aug 31 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.72 | 50,000 | 35,750 | 832,200 | 782.2 K to 832.2 K (+6.39 %) |
| Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.60 | 200,000 | 120,000 | 200,000 |
Page: 1